Advancing innovation in accelerated cancer diagnosis
Summary
Innovate UK is offering up to £25.4 million to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. This funding is for researchers and startups developing innovative solutions for accelerated cancer diagnosis. The key requirement is to demonstrate the clinical validity and evaluability of the proposed technologies.
Eligibility Criteria
* Applicants must be a UK-registered business, research organisation or public sector organisation. * Projects must focus on early cancer diagnosis technologies and devices. * Funding is for clinical validation and evaluation stages. * Collaboration between industry and academic/research institutions is encouraged.
How to Apply
Applications are submitted through the Innovate UK website. Potential applicants should carefully review the full competition brief on the UKRI website for detailed instructions, eligibility criteria, and assessment process. Key documents will likely include a project proposal, detailed budget, and evidence of clinical need and potential impact. Focus on clear articulation of the technology's novelty, clinical utility, and validation plan.